Sangamo Therapeutics (SGMOQ) EBT Margin Growth (1y) (2011 - 2025)
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) EBT Margin Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.13 Bn | 9.29 Bn | 112.79 Mn | 672.00 |
| 2 | CRISPR Therapeutics AG | 5.23 Bn | 5.23 Bn | - | 2.23 Mn |
| 3 | Iovance Biotherapeutics | 3.82 Bn | 3.52 Bn | 55.72 Mn | 13,390.00 |
| 4 | Legend Biotech | 3.68 Bn | 2.72 Bn | 251.50 Mn | 6,324.00 |
| 5 | uniQure | 3.08 Bn | 3.08 Bn | 5.49 Mn | -64,750.00 |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - | -2.31 Mn |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | 314,854.00 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.54 Bn | 251.87 Mn | -2,558.00 |
| 9 | Vericel | 2.00 Bn | 1.84 Bn | 56.40 Mn | 371.00 |
| 10 | Sangamo Therapeutics | 43.15 Mn | 22.20 Mn | - | 9,963.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 9,963.00 |
| Sep 30, 2025 | -606,154.00 |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 971,176.00 |
| Dec 31, 2024 | 259,955.00 |
| Sep 30, 2024 | 111,662.00 |
| Jun 30, 2024 | -836,059.00 |
| Mar 31, 2024 | -1.02 Mn |
| Dec 31, 2023 | -277,615.00 |
| Sep 30, 2023 | -89,406.00 |
| Jun 30, 2023 | -162,026.00 |
| Mar 31, 2023 | 16,907.00 |
| Dec 31, 2022 | -5,569.00 |
| Sep 30, 2022 | -3,412.00 |
| Jun 30, 2022 | 2,249.00 |
| Mar 31, 2022 | 1,824.00 |
| Dec 31, 2021 | 2,302.00 |
| Sep 30, 2021 | -16,446.00 |
| Jun 30, 2021 | -230.00 |
| Mar 31, 2021 | 15,484.00 |